Spots Global Cancer Trial Database for cytoxan
Every month we try and update this database with for cytoxan cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse | NCT00083681 | Multiple Myelom... | Thalidomide Dexamethasone Cytoxan Etoposide Cisplatin G-CSF | 18 Years - | University of Arkansas | |
| Cord Blood Natural Killer (NK) Cells in Leukemia/Lymphoma | NCT02280525 | Leukemia | Lenalidomide Rituximab Fludarabine Cyclophosphamid... NK Cells Cytarabine | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Adoptive Therapy Using Antigen-Specific CD4 T-Cells | NCT02210104 | Melanoma Sarcoma | Ipilimumab Cyclophosphamid... CD4+ T cells | 18 Years - | M.D. Anderson Cancer Center | |
| Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies | NCT01203722 | Hematologic Mal... | Fludarabine Cytoxan Total Body Irra... Allogeneic Bloo... Peripheral Bloo... Mycophenolate M... Sirolimus Tacrolimus | 6 Months - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Molecular Triaging of Newly Diagnosed Breast Cancer | NCT01159236 | Breast Cancer | Paclitaxel Fluorouracil Doxorubicin Epirubicin Cyclophosphamid... Bevacizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies | NCT00856180 | Ovarian Cancer Peritoneal Canc... Fallopian Tube ... | Bevacizumab Cyclophosphamid... | 18 Years - | Dana-Farber Cancer Institute | |
| Randomized Double Cord Blood Transplant Study | NCT00067002 | Leukemia, Lymph... Leukemia, Myelo... Leukemia, Myelo... Lymphoma, Non-H... | Expanded alloge... One Unmanipulat... Rituxan Melphalan Thiotepa Fludarabine Cyclophosphamid... Mesna Total body irra... | 1 Month - 80 Years | M.D. Anderson Cancer Center | |
| A Phase 2 Trial for Patients With Metastatic Solid Cancer | NCT04713371 | Metastatic Canc... | Keytruda Inject... Yervoy Injectab... Cytoxan Cryosurgical fr... GM-CSF Injectab... | 18 Years - | Rampart Health, L.L.C. | |
| Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL) | NCT00941928 | Leukemia Pediatric Cance... | Epratuzumab Fludarabine Cyclophosphamid... Mesna Infusion of NK ... Interleukin-2 | - | M.D. Anderson Cancer Center | |
| Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) | NCT02441803 | Leukemia | Busulfan Fludarabine Clofarabine Total Body Irra... Thymoglobulin Stem Cell Infus... Cyclophosphamid... Tacrolimus Mycophenolate m... Decitabine Cytarabine Idarubicin | 18 Years - 60 Years | M.D. Anderson Cancer Center | |
| Adj TC + Herceptin Early Stage Breast Cancer | NCT00493649 | Breast Cancer | Taxotere Cytoxan Herceptin | 18 Years - 70 Years | US Oncology Research | |
| Treatment of Tumors of the Choroid Plexus Epithelium | NCT00500890 | Choroid Plexus ... | Carboplatin Cyclophosphamid... Etoposide Vincristine Radiation Thera... | - | M.D. Anderson Cancer Center | |
| Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention | NCT02423915 | Leukemia Lymphoma | Rituximab Fludarabine Cyclophosphamid... Total Body Radi... Fucosylated Reg... Cord Blood Infu... Mycophenolate m... Sirolimus Bone Marrow Asp... G-CSF Non-Fucosylated... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Safety and Efficacy of Campath in Nonmyeloablative Transplantation | NCT00038844 | Lymphoma Leukemia | Campath-1 H (Al... Fludarabine Cyclophosphamid... Rituximab | - 70 Years | M.D. Anderson Cancer Center | |
| Exemestane or Docetaxel-Cytoxan in Low Recurrence Score Cancers | NCT00941330 | Breast Cancer | Exemestane Docetaxel Cytoxan | 18 Years - | Emory University | |
| Primary Breast Cancer Occurring Concomitant With Pregnancy | NCT00510367 | Breast Cancer Pregnancy | 5-Fluorouracil Cyclophosphamid... Doxorubicin | - | M.D. Anderson Cancer Center | |
| Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer | NCT00136539 | Breast Cancer | Herceptin Taxol Adriamycin Cytoxan | 18 Years - | Dana-Farber Cancer Institute | |
| Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer | NCT02995330 | Prostate Cancer | Bone marrow tra... Cytoxan testosterone cy... | 18 Years - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia | NCT00230282 | Leukemia B-cell Leukemia Chronic Leukemi... Chronic Lymphoc... | Alemtuzumab Fludarabine Cytoxan | 18 Years - | Stanford University | |
| Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY | NCT00809276 | Lymphoma Multiple Myelom... Leukemia Myelodysplastic... | Busulfan, Fluda... | - 65 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies | NCT01247701 | Myeloid Hematol... | Busulfan Cyclophosphamid... Fludarabine Cord Blood Stem... | - 17 Years | Baylor College of Medicine | |
| Anti-CD33 CAR NK Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia | NCT05008575 | Leukemia, Myelo... | anti-CD33 CAR N... Fludarabine Cytoxan | 18 Years - 70 Years | Xinqiao Hospital of Chongqing | |
| Cord Blood Natural Killer (NK) Cells in Leukemia/Lymphoma | NCT02280525 | Leukemia | Lenalidomide Rituximab Fludarabine Cyclophosphamid... NK Cells Cytarabine | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia | NCT00446173 | Leukemia | Busulfan Cyclophosphamid... G-CSF GM-CSF | 21 Years - 65 Years | M.D. Anderson Cancer Center | |
| Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies | NCT00856180 | Ovarian Cancer Peritoneal Canc... Fallopian Tube ... | Bevacizumab Cyclophosphamid... | 18 Years - | Dana-Farber Cancer Institute | |
| Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) | NCT01082939 | Chronic Lymphoc... | Fludarabine Cyclophosphamid... Alemtuzumab Rituximab | - | M.D. Anderson Cancer Center | |
| Autologous Transplantation for Chronic Myelogenous Leukemia | NCT01003054 | Chronic Myeloge... | Busulfan Cyclophosphamid... Imatinib Mesyla... Autologous Stem... | - 70 Years | M.D. Anderson Cancer Center | |
| VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies | NCT03885947 | Hematological M... Acute Leukemia ... Acute Lymphobla... Myelodysplastic... Non-Hodgkin Lym... Hodgkin Lymphom... | Cord blood stem... Valproic Acid Fludarabine cytoxan Thiotepa TBI | 18 Years - 65 Years | Icahn School of Medicine at Mount Sinai | |
| Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23) | NCT01253460 | Leukemia | Cyclophosphamid... Rituximab Sapacitabine | 18 Years - | M.D. Anderson Cancer Center | |
| Anti-CD33 CAR NK Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia | NCT05008575 | Leukemia, Myelo... | anti-CD33 CAR N... Fludarabine Cytoxan | 18 Years - 70 Years | Xinqiao Hospital of Chongqing | |
| Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies | NCT00048737 | Lymphoma Leukemia | Zevalin Radioim... Rituximab Fludarabine Cyclophosphamid... Allogeneic Stem... | 18 Years - 70 Years | M.D. Anderson Cancer Center | |
| Exemestane or Docetaxel-Cytoxan in Low Recurrence Score Cancers | NCT00941330 | Breast Cancer | Exemestane Docetaxel Cytoxan | 18 Years - | Emory University | |
| Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia | NCT00002844 | Leukemia | Cyclophosphamid... Allogeneic Bone... Autologous Bone... Total Body Irra... | 16 Years - 65 Years | M.D. Anderson Cancer Center | |
| SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma | NCT00787527 | Lymphoma | Zolinza (vorino... Cyclophosphamid... Doxorubicin Vincristine Prednisone | 18 Years - | M.D. Anderson Cancer Center | |
| Adj TC + Herceptin Early Stage Breast Cancer | NCT00493649 | Breast Cancer | Taxotere Cytoxan Herceptin | 18 Years - 70 Years | US Oncology Research | |
| Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies | NCT00857389 | Stem Cell Trans... Leukemia Lymphoma | Thiotepa Clofarabine Busulfan Allogeneic Stem... Thymoglobulin (... G-CSF (Filgrast... Tacrolimus Methotrexate Cyclophosphamid... Mesna | - 60 Years | M.D. Anderson Cancer Center | |
| Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma | NCT01313884 | Bone Cancer Ewing's Sarcoma | Irinotecan Vincristine Temozolomide Doxorubicin Cytoxan Pegfilgrastim | 13 Years - | Stanford University | |
| Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer | NCT00136539 | Breast Cancer | Herceptin Taxol Adriamycin Cytoxan | 18 Years - | Dana-Farber Cancer Institute | |
| HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA | NCT02379520 | Human Papilloma... Human Papilloma... Human Papilloma... Human Papilloma... Human Papilloma... Human Papilloma... | HPV Specific T ... Cytoxan Fludarabine Nivolumab | 18 Years - | Baylor College of Medicine | |
| DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse | NCT00083681 | Multiple Myelom... | Thalidomide Dexamethasone Cytoxan Etoposide Cisplatin G-CSF | 18 Years - | University of Arkansas | |
| FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years | NCT00254410 | Chronic Lymphoc... | Fludarabine Cyclophosphamid... Mitoxantrone Rituximab Filgrastim | - 70 Years | M.D. Anderson Cancer Center | |
| Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia | NCT00002844 | Leukemia | Cyclophosphamid... Allogeneic Bone... Autologous Bone... Total Body Irra... | 16 Years - 65 Years | M.D. Anderson Cancer Center | |
| Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma | NCT00698009 | Neuroblastoma | Fludarabine Cyclophosphamid... Natural Killer ... Mesna Interleukin-2 | - | M.D. Anderson Cancer Center | |
| Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer | NCT00136539 | Breast Cancer | Herceptin Taxol Adriamycin Cytoxan | 18 Years - | Dana-Farber Cancer Institute | |
| Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer | NCT00146588 | Breast Cancer Stage I Breast ... Stage II Breast... Stage IIIA Brea... | Cyclophosphamid... Epirubicin Capecitabine | 18 Years - | Dana-Farber Cancer Institute | |
| Pancreatic Tumor Cell Vaccine (GVAX), Low Dose Cyclophosphamide, Fractionated Stereotactic Body Radiation Therapy (SBRT), and FOLFIRINOX Chemotherapy in Patients With Resected Adenocarcinoma of the Pancreas | NCT01595321 | Pancreatic Canc... | Cyclophosphamid... PANC 10.05 pcDN... Stereotactic Bo... FOLFIRINOX | 18 Years - 76 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer | NCT00038402 | Breast Cancer | Herceptin Taxol Fluorouracil Cytoxan Epirubicin | - | M.D. Anderson Cancer Center | |
| Safety and Efficacy of Campath in Nonmyeloablative Transplantation | NCT00038844 | Lymphoma Leukemia | Campath-1 H (Al... Fludarabine Cyclophosphamid... Rituximab | - 70 Years | M.D. Anderson Cancer Center | |
| Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention | NCT02423915 | Leukemia Lymphoma | Rituximab Fludarabine Cyclophosphamid... Total Body Radi... Fucosylated Reg... Cord Blood Infu... Mycophenolate m... Sirolimus Bone Marrow Asp... G-CSF Non-Fucosylated... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer | NCT06409390 | Metastatic Brea... | Taxotere Cytoxan Trastuzumab der... Sacituzumab gov... Xeloda Fulvestrant Ribociclib Abemaciclib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing | NCT00381173 | Breast Cancer Ovarian Cancer Prostate Cancer Colon Cancer Renal Cancer | Cyclophosphamid... | 18 Years - | Eisai Inc. | |
| Adoptive Therapy Using Antigen-Specific CD4 T-Cells | NCT02210104 | Melanoma Sarcoma | Ipilimumab Cyclophosphamid... CD4+ T cells | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Bortezomib in Combination With Cyclophosphamide and Rituximab | NCT00958256 | Mantle Cell Lym... Lymphoma | Bortezomib Rituximab Cyclophosphamid... Mesna G-CSF | 18 Years - 85 Years | M.D. Anderson Cancer Center | |
| Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer | NCT00429182 | Breast Cancer Metastatic Brea... Invasive Breast... | Carboplatin Cyclophosphamid... Thiotepa Stem Cell Trans... | 18 Years - 55 Years | M.D. Anderson Cancer Center | |
| Autologous Transplantation for Chronic Myelogenous Leukemia | NCT01003054 | Chronic Myeloge... | Busulfan Cyclophosphamid... Imatinib Mesyla... Autologous Stem... | - 70 Years | M.D. Anderson Cancer Center | |
| Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally | NCT00083538 | Multiple Myelom... | Dexamethasone Thalidomide Cisplatinum Adriamycin Cyclophosphamid... Etoposide | 18 Years - | University of Arkansas | |
| Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer | NCT02995330 | Prostate Cancer | Bone marrow tra... Cytoxan testosterone cy... | 18 Years - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer | NCT00866905 | Breast Cancer | Ixabepilone Cyclophosphamid... | 18 Years - | SCRI Development Innovations, LLC | |
| Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting | NCT02004262 | 2nd-line, 3rd-l... | GVAX Pancreas V... CRS-207 Chemotherapy cyclophosphamid... | 18 Years - | Aduro Biotech, Inc. | |
| TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma | NCT01039025 | Myeloma | Topotecan Cyclophosphamid... Melphalan Peripheral Bloo... | - 70 Years | M.D. Anderson Cancer Center | |
| Adoptive Therapy Using Antigen-Specific CD4 T-Cells | NCT02210104 | Melanoma Sarcoma | Ipilimumab Cyclophosphamid... CD4+ T cells | 18 Years - | M.D. Anderson Cancer Center | |
| Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies | NCT01203722 | Hematologic Mal... | Fludarabine Cytoxan Total Body Irra... Allogeneic Bloo... Peripheral Bloo... Mycophenolate M... Sirolimus Tacrolimus | 6 Months - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Anti-BCMA CAR-NK Cell Therapy for the Relapsed or Refractory Multiple Myeloma | NCT05008536 | Multiple Myelom... | Anti-BCMA CAR-N... Fludarabine Cytoxan | 18 Years - 70 Years | Xinqiao Hospital of Chongqing | |
| Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies | NCT01247701 | Myeloid Hematol... | Busulfan Cyclophosphamid... Fludarabine Cord Blood Stem... | - 17 Years | Baylor College of Medicine | |
| Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger | NCT00290498 | Lymphoma | Rituximab Cyclophosphamid... Doxorubicin Vincristine Dexamethasone Methotrexate Cytarabine Prednisone | 16 Years - 60 Years | M.D. Anderson Cancer Center | |
| DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse | NCT00083681 | Multiple Myelom... | Thalidomide Dexamethasone Cytoxan Etoposide Cisplatin G-CSF | 18 Years - | University of Arkansas | |
| Cord Blood Natural Killer (NK) Cells in Leukemia/Lymphoma | NCT02280525 | Leukemia | Lenalidomide Rituximab Fludarabine Cyclophosphamid... NK Cells Cytarabine | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Safety and Efficacy of Campath in Nonmyeloablative Transplantation | NCT00038844 | Lymphoma Leukemia | Campath-1 H (Al... Fludarabine Cyclophosphamid... Rituximab | - 70 Years | M.D. Anderson Cancer Center | |
| Non-Myeloablative Allogeneic Stem Cell Transplantation | NCT00525876 | Lymphoma | Cyclophosphamid... Fludarabine Rituximab Alemtuzumab Allogeneic Stem... | - 70 Years | M.D. Anderson Cancer Center | |
| Umbilical Cord Blood Transplant for Children With Lymphoid Hematological Malignancies | NCT01247688 | Lymphoid Hemato... Umbilical Cord ... | Cytoxan Fludarabine Total Body Irra... Cord Blood Stem... | - | Baylor College of Medicine | |
| Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally | NCT00083538 | Multiple Myelom... | Dexamethasone Thalidomide Cisplatinum Adriamycin Cyclophosphamid... Etoposide | 18 Years - | University of Arkansas | |
| Treatment of Tumors of the Choroid Plexus Epithelium | NCT00500890 | Choroid Plexus ... | Carboplatin Cyclophosphamid... Etoposide Vincristine Radiation Thera... | - | M.D. Anderson Cancer Center | |
| Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma | NCT00578864 | Neuroblastoma | Protracted Oral... Doxorubicin IV Bolus Etopos... Cisplatin Cyclophosphamid... Mesna Hematopoietic F... Primary tumor r... | - | Baylor College of Medicine | |
| Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) | NCT02441803 | Leukemia | Busulfan Fludarabine Clofarabine Total Body Irra... Thymoglobulin Stem Cell Infus... Cyclophosphamid... Tacrolimus Mycophenolate m... Decitabine Cytarabine Idarubicin | 18 Years - 60 Years | M.D. Anderson Cancer Center | |
| Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies | NCT00856180 | Ovarian Cancer Peritoneal Canc... Fallopian Tube ... | Bevacizumab Cyclophosphamid... | 18 Years - | Dana-Farber Cancer Institute | |
| Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP) | NCT02932956 | Liver Cancer | GAP T cells Cytoxan Fludara | 1 Year - 21 Years | Baylor College of Medicine | |
| Molecular Triaging of Newly Diagnosed Breast Cancer | NCT01159236 | Breast Cancer | Paclitaxel Fluorouracil Doxorubicin Epirubicin Cyclophosphamid... Bevacizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 | NCT01593020 | Breast Cancer | Paclitaxel Eribulin 5-Fluorouracil Epirubicin Cyclophosphamid... Doxorubicin | 18 Years - | M.D. Anderson Cancer Center | |
| Primary Breast Cancer Occurring Concomitant With Pregnancy | NCT00510367 | Breast Cancer Pregnancy | 5-Fluorouracil Cyclophosphamid... Doxorubicin | - | M.D. Anderson Cancer Center | |
| Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells | NCT01362452 | Leukemia Lymphoma | T-Cell Infusion Cord Blood Infu... | 1 Year - 75 Years | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
